聚羟基丁酯酯缓释微球的制备及性能

用溶剂蒸发法制备了以新型生物可降解材料聚羟基丁酸酯为载体、以安定为模药的缓释微球,讨论了药物与载体之比对药物含量与包封率的影响,以及制备微球条件对药物释放性能的影响;微球平均粒径为３０～４０μｍ,粒径分布在１～１．５之间,最大载药量为１９．５１％;最高包封率为６７．１１％;体外累积释放曲线呈“两相”释放特征并拌随初始的“突释效应”。扫描电镜观察微球表面呈皱缩表观形态结构,微球内部横断面具有孔道与孔     

聚羟基丁酸酯缓释微球的制备与性能

用溶剂蒸发法制备了以新型生物可降解材料聚羟基丁酸酯为载体、以安定为模药的缓释微球,讨论了药物与载体之比对药物含量与包封率的影响,以及制备微球条件对药物释放性能的影响;微球平均粒径为30～40 μm,粒径分布在 1～1.5之间,最大载药量为19.51%;最高包封率为67.11%;体外累积释放曲线呈"两相"释放特征并拌随初始的"突释效应".扫描电镜观察微球表面呈皱缩表观形态结构,微球内部横断面具有孔道与孔洞,在4℃与室温(20～25 ℃)条件下密封,避光环境下性质稳定.     

聚[1,3-双(对羧基苯氧基)丙烷-癸二酸](20:80)-替莫唑胺长效缓释微球的制备及药物缓释性能的研究

合成了聚[1,3-双(对羧基苯氧基)丙烷-癸二酸](20:80)(CPP-SA),并利用喷雾干燥法制备了替莫唑胺Temozolomide(TMZ)-(CPP-SA)缓释微球。通过对TMZ的不同包合方法的研究,确定了喷雾干燥法作为制备此类微球的最佳方法,获得了良好的药物缓释曲线。结果表明,微球对药物释放曲线平稳,释放时间长,能超过800h。为抗肿瘤药物TMZ的体内植入提供了有意义的理论依据。     

循环应力下PLGA多孔支架对地塞米松的控制释放

摘要 采用喷雾干燥法制备包载地塞米松(Dex)的聚L-丙交酯-b-聚乙二醇(PLLA-PEG)微球, 以热致相分离/粒子洗去法制备聚乙交酯-co-丙交酯(PLGA)多孔支架, 通过复合溶结法将载药微球固定于PLGA多孔支架中, 制得载药微球-支架(记为MS-S). 另外, 在支架制备过程中将Dex直接加入PLGA溶液中, 制得对比的直接载药支架(记为D-S). 以扫描电镜观察微球和支架的微观形貌, 在循环压应力与水浴摇床两种环境下分别对上述两种载药支架进行控制释放Dex的实验, 用紫外-可见光分光光度计测定Dex的累积释放量. 结果表明, Dex及微球的载入对PLGA支架的整体形貌影响较小; 循环压应力显著提高了Dex从载药支架中的释放速率, 与D-S相比, MS-S延缓了药物的释放. 研究模拟体内循环压应力下支架控制释放药物规律对于实现理想的临床效果具有重要意义.     

聚氨酯缓释微球的制备及其体外释放性能的研究

用悬浮缩聚法制备了可生物降解的聚氨酯微球,以硝苯地平为模拟药物,讨论了影响药物释放性能的一些因素。结果表明,当摩尔比nNC0-/nOH-=5／6,摩尔比n-OH-(PEG)／n-OH-(LIG)=1／5时,所得的微球包封率为78．22％,载药量为16．72％,平均粒径为68．20μm,粒径分布为1．83,微球的释放性能最好,而且载药微球对温度和湿度的稳定性较好。     

聚蔗糖微球缓释载体的研制

药物输送系统(drug delivery system,DDS)主要包括药物和载体两部分,微球(microspheres)是以适宜的高分子材料制成的一种应用较为广泛的新型药物载体。本文研究了聚蔗糖微球的制备方法以及作为药物缓释载体的可行性。以Span-80为表面活性剂,环氧氯丙烷为交联剂,Ficoll-400水溶液为水相(W),氯苯为油相(O),采用反相悬浮聚合法制备了一系列粒径<100μm、圆球率高的聚蔗糖微球。以牛血清蛋白(BSA)为模型药物,研究其作为药物载体的缓释性能。释放实验表明其最大释放率为95%,适当提高其交联程度有利于BSA的缓慢释放。     

栓塞型新型微包纳药物控释载体的制备及性能

为了抑制药物的突释效应, 减缓药物的释放速率, 实现不同药物的空间分配及顺序释放, 采用乳化法结合高压静电液滴法, 制备了内部包埋有几丁聚糖/海藻酸钙纳米囊的聚精氨酸/几丁聚糖/海藻酸盐微包纳体系(Nano-in-micro drug delivery system, NiM). 通过荧光标记的方法证实了“微包纳”结构并考察了NiM的理化性能. 以牛血清白蛋白及氟尿嘧啶作为药物模型, 考察了聚精氨酸/几丁聚糖/海藻酸盐微包纳体系对单一蛋白类药物和负载两种药物的缓释性能并进行了动力学模型拟合. 结果表明, Ritger-Peppas模型能够较好地模拟该溶胀控释系统的药物释放过程, 与实验结果比较吻合. 同时也证明了该新型载体体系具有无突释、释放速率减缓及顺序释放的功能, 为新型药物载体体系的研究提供了新的思路.     

聚合物微纳米管的制备技术

由于聚合物微纳米管独特的一维中空结构和性能多样性,在分离、电子器件、催化剂负载、药物释放等方面具有广泛的应用前景,本文结合最新的研究进展,总结了聚合物微纳米管的制备方法,并重点介绍了硬模板法、软模板法和无模板法的特点。     

盐溶液调控海藻酸钙微球中的自由羧酸根及其对阿霉素的装载和释放行为研究

采用膜乳化-凝胶化法制备了粒径窄分布的海藻酸钙微球.用不同浓度的氯化钠溶液处理微球来调控微球中的自由羧酸根的含量.用原子吸收光谱和红外光谱表征了微球中钙、钠离子以及化学基团的变化,证明盐处理后海藻酸钙微球内发生了钠离子置换钙离子的过程,海藻酸中的羧酸根由螯合态转变为自由态.用盐处理后的微球吸附带正电荷的小分子抗癌药物阿霉素的能力大大提高,其中用浓度1.8%的氯化钠溶液处理后的微球载药量达到1310μg/mg,是未处理微球的10倍.负载药物的微球具有pH敏感的释放行为,在pH5.5的PBS溶液中的释放速率和释放量显著大于在pH 7.4的PBS溶液中.     

直接缩聚法海藻酸钠/乳酸低聚物接枝共聚物的合成及释药性能研究

通过直接缩聚法使乳酸与海藻酸钠接枝聚合,实现了对海藻酸钠的疏水改性。结果发现,疏水改性后的海藻酸钠水溶液中出现粒径为80~110nm的颗粒,说明海藻酸钠接枝改性成功。将改性后的海藻酸钠溶液滴入到氯化钙溶液中制备成直径1.5mm左右凝胶微球。以布洛芬为药物模型进行释放研究,结果表明,所得凝胶微球对药物的载药率和包封率较改性前得到提高,缓释效果增强。药物在弱碱性溶液中释放比较快,而在酸性环境中基本不释放。利用此特点,可将共聚物制备成药物载体,用于肠道内的控制释放。     

Relationship among drug delivery behavior,degradation behavior and morphology of copolylactones derived from glycolide,l‐lactide and ε‐caprolactone

A series of copolylactones was synthesized by ring‐opening copolymerization of glycolide, L ‐lactide and ?‐caprolactone, using stannous octoate as catalyst. The in vitro degradation behaviors of them were studied and data demonstrated different degradation rates which mainly depended on the compositions. Investigation of the 5‐fluorouracil (5‐Fu) release from these copolylactones revealed that the composition, degradation rate and the morphology of the polymeric matrix played an important role on the drug release kinetics. A sustained 5‐Fu release without initial time lag was obtained from random poly(lactide‐co‐glycolide‐co‐caprolactone) (r‐PGLC) drug carrier, and it differed from the cases of polylactide (PLA) or random poly(lactide‐co‐glycolide) (PLGA), which usually showed an initial time lag or biphasic drug release behavior. It was due to the low glass transition temperature (T _g) of the r‐PGLC and the drug would diffuse faster in rubbery state under the experimental temperature. Furthermore, a significant change in the drug release behavior of r‐PGLC was observed when the temperatures were changed around the T _g of the drug carrier, which implied that the drug release behavior could be regulated by adjusting the morphology of the drug carrier. Copyright © 2002 John Wiley & Sons, Ltd.     

Hyperbranched poly (amine‐ester)‐poly (lactide‐co‐glycolide) copolymer and their nanoparticles as paclitaxel delivery system

A new hyperbranched poly (amine‐ester)‐poly (lactide‐co‐glycolide) copolymer (HPAE‐co‐PLGA) was synthesized by ring‐opening polymerization of D , L ‐lactide (DLLA) glycolid and branched poly (amine‐ester) (HPAE‐OHs) with Sn(Oct)₂ as catalyst. The chemical structures of copolymers were determined by FT‐IR, ¹H‐NMR(¹³C NMR), TGA and their molecular weights were determined by gel permeation chromatography (GPC). Paclitaxel‐loaded copolymer nanoparticles were prepared by the nanoprecipitation method. Their physicochemical characteristics, e.g. morphology and nanoparticles size distribution were then evaluated by means of fluorescence spectroscopy, environmental scanning electron microscopy (ESEM), and dynamic light scattering (DLS). Paclitaxel‐loaded nanoparticles assumed a spherical shape and have unimodal size distribution. It was found that the chemical composition of the nanoparticles was a key factor in controlling nanoparticles size, drug‐loading content, and drug release behavior. As the molar ratio of DL ‐lactide/glycolide to HPAE increased, the nanoparticles size and drug‐loading content increased, and the drug release rate decreased. The antitumor activity of the paclitaxel‐loaded HPAE‐co‐PLGA nanoparticles against human liver cancer H7402 cells was evaluated by 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) method. The paclitaxel‐loaded HPAE‐co‐PLGA nanoparticles showed comparable anticancer efficacy with the free drug. Copyright © 2010 John Wiley & Sons, Ltd.     

The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant

Biodegradable in situ forming drug delivery systems for naltrexone release are promising for post‐treatment of drug addicts. The effect of two different additives, glycerol and ethyl heptanoate, on the naltrexone hydrochloride release and solvent removal from a poly(DL ‐lactide‐co‐glycolide) (PLGA) injectable implant is presented in this article. The experimental results showed that the in vitro initial release of the drug was decreased in the presence of these additives. Ethyl heptanoate was, however, more effective than glycerol and increasing the amount of additives in PLGA solution up to 5% (w/w) resulted in a decrease of initial naltrexone release rate up to 50%. The morphological evaluation of implants using scanning electron microscopy indicated that the additives generated a less porous structure together with a finger‐like to sponge‐like transition. The solvent removal profiles of injectable implants, which can be well described by thermogravimetric and morphological analysis, were in good agreement with drug release profiles. Copyright © 2006 John Wiley & Sons, Ltd.     

Synthesis and non‐isothermal crystallization kinetics of poly(ethylene terephthalate)‐co‐poly(propylene glycol) copolymers

Poly(ethylene terephthalate)‐co‐poly(propylene glycol) (PET‐co‐PPG) copolymers with PPG ratio ranging from 0 to 0.90 mol% were synthesized by the melt copolycondensation. The intrinsic viscosity, structure, non‐isothermal crystallization behavior, nucleation and spherulitic growth of the copolymers were investigated by Ubbelohde viscometer, Proton Nuclear Magnetic Resonance (¹H‐NMR), differential scanning calorimetry, and polarized optical microscopy, respectively. The non‐isothermal crystallization process of the copolymers was analyzed by Avrami, Ozawa, Mo's, Kissinger, and Dobreva methods, respectively. The results showed that the crystallizability of PET was apparently enhanced with incorporating a small amount of PPG, which first rose and then reduced with increasing amount of PPG in the copolymers at a given cooling rate. The crystallization mechanism was a three‐dimensional growth with both instantaneous and sporadic nucleation. Particularly, PET‐co‐PPG containing 0.60 mol% PPG exhibited the highest crystallizability among all the copolymers. Copyright © 2015 John Wiley & Sons, Ltd.     

Robust Poly(allylamine)‐graft‐poly(N‐isopropylacrylamide) Particles Prepared by Physical Crosslinking with Poly(styrene sulfonate)

Summary: Robust thermosensitive PAH‐g‐PNIPAAm/PSS particles were prepared by addition of a poly(allylamine)‐graft‐poly(N‐isopropylacrylamide) particle suspension into poly(styrene sulfonate) solution above the LCST of PAH‐g‐PNIPAAm. Scanning force microscopy revealed stable and well‐separated particles in water at room temperature. The zeta‐potential showed a negative surface charge of the particles. Their thermosensitive behavior was demonstrated by dynamic light scattering. The release of rhodamine 6G loaded particles could respond to the incubation temperature.

Fabrication of thermosensitive and robust particle by suspension of in situ formed PAH‐g‐PNIPAAm particle above the LCST in PSS solution.     

Synthesis and hydrolytic degradation of a random copolymer derived from 1,4‐dioxan‐2‐one and glycolide

Novel biodegradable copolymers, poly(1,4‐dioxan‐2‐one‐co‐glycolide) [P(DON‐co‐GA)] containing a high proportion of 1,4‐dioxan‐2‐one (DON), were synthesized by copolymerizations of DON and glycolide (GA) at 120 °C for 16 h using stannous octoate as catalyst. Chemical composition and microstructural variation of the resulting copolymer were investigated by ¹H‐ and ¹³C NMR and thermal properties by differential scanning calorimetry (DSC). From the ¹³C NMR spectra, it was observed that, apart from the expected preponderance of DON sequences, the minor component, GA, was indeed distributed at various points along the copolymer chain rather than incorporated as distinct blocks, which is consistent with a random sequence distribution. This view also was supported by the DSC results, which showed that most copolymers were amorphous except for one with a relatively high fraction of DON. The conclusion that it was a random structure rather than a statistical copolymer is discussed, using the theories about the mechanism of this type of polymerization in current as a reference. P(DON‐co‐GA) films were prepared by casting the copolymer solution in hexafluoroisopropanol (HFIP) with two concentrations of the polymeric solution (10 and 25 wt %). The in vitro hydrolytic degradation behaviors of these films were studied in phosphate buffer solution (pH = 7.4) at 37 °C and characterized by DSC, scanning electron microscopy, weight loss, and change in inherent viscosity. © 2004 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 42: 2558–2566, 2004     

Nanoporous Crosslinked Copolymers Prepared by Thermal Degradation of Poly(Methacryl‐N,N′‐diisopropylurea‐co‐ethylene Glycol Dimethacrylate)

Abstract

Copolymers of methacryl‐N,N′‐diisopropylurea (MA‐DiPrU) with ethylene glycol dimethacrylate (EDMA) at monomer‐to‐monomer ratios in the feed: 0.3/0.7; 0.5/0.5; 0.7/0.3; 0.8/0.2 were prepared in butanone in the presence of 2% of dibenzoyl peroxide (Bz₂O₂) at 70°C for 48?hr. Copolymers regardless of the ratio of comonomers in the feed decompose thermally at 200–250°C under the separation of isopropylisocyanate (iPrNCO). Residues after the removal of iPrNCO are thermally stable nanoporous crosslinked copolymers of methacryl‐isopropylamide (MA‐iPrA) with EDMA which decompose by a one‐step mechanism between 280°C and 450°C. Nonporous model copolymers poly(MA‐iPrA‐co‐EDMA) of similar composition, prepared by copolymerization of MA‐iPrA with EDMA, also decomposed by a one‐step mechanism as shown by TGA measurements.     

Preparation and characterization of macroporous poly(N‐isopropylacrylamide) hydrogels for the controlled release of proteins

Macroporous, temperature‐sensitive poly(N‐isopropylacrylamide) (PNIPAAm) hydrogels were synthesized with poly(ethylene glycol)s (PEGs; molecular weight = 2000–6000) as the pore‐forming agents. The influence of the molecular weight and PEG content on the responsive kinetics of these macroporous hydrogels was investigated. The PEG‐modified PNIPAAm hydrogels were characterized by the swelling ratio, deswelling–reswelling kinetics, Fourier transform infrared, and differential scanning calorimetry. The morphology of these hydrogels was analyzed with scanning electron microscopy. The prepared macroporous hydrogels exhibited some unique properties in comparison with the gels with low molecular weight PEGs (molecular weight < 2000) as the pore‐forming agents. In addition, a preliminary study on the controlled release of bovine serum albumin from these macroporous hydrogels was carried out. © 2002 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 41: 152–159, 2003     

Thermosensitive polylactide‐glycolide delivery systems for treatment of narcotic addictions

Environmental switches may be fabricated for the controlled release of pharmaceutical drug using a thermally responsive polymer with the intrinsic chemical and physical nature of stimuli‐sensitive smart materials. Particularly, much attention has been paid to the biomedical applications of poly(N‐isopropyl acrylamide) (PNIPAAm) because of its unique reversible transition at a specific lower critical solution temperature (LCST).Thermally sensitive block copolymers, poly(N‐isopropyl acrylamide‐b‐poly(L ‐lactide‐co‐glycolide) (PNIPAAm‐b‐PLGA), and polyethylene glycol‐poly (lactide‐co‐glycolide) (PEG‐PLGA) triblock copolymers with different compositions and length of PLGA block were synthesized via ring‐opening polymerization of lactide and glycolide in the presence of OH‐terminated PNIPAAm or PEG. The composition and structure of the polymer were determined by NMR and FTIR. The effect of important factors, such as ionic strength, pH, and polymer concentration on the phase transition behavior of temperature‐sensitive polymers, were investigated by cloud point measurements. The resulting thermosensitive polymers were used for the entrapment of a narcotic antagonist drug, naltrexone, as the model drug. The loading efficiency and drug release behavior of naltrexone‐loaded hydrogels were investigated. The naltrexone loaded thermosensitive polymers were able to sustain the release of naltrexone for different periods of time, depending on the polymer composition, and concentration. In vitro release studies showed that these thermosensitive polymers are able to deliver naltrexone in biologically active forms at a controlled rate for 3–8 weeks. Copyright © 2009 John Wiley & Sons, Ltd.     

Novel poly(N‐isopropylacrylamide)/clay/poly(acrylamide) IPN hydrogels with the response rate and drug release controlled by clay content

Novel interpenetrating network (IPN) hydrogels (PNIPAAm/clay/PAAm hydrogels) based on poly(N‐isopropylacrylamide) (PNIPAAm) crosslinked by inorganic clay and poly(acrylamide) (PAAm) crosslinked by organic crosslinker were prepared in situ by ultraviolet (UV) irradiation polymerization. The effects of clay content on temperature dependence of equilibrium swelling ratio, deswelling behavior, thermal behavior, and the interior morphology of resultant IPN hydrogels were investigated with the help of Fourier transform infrared spectroscopy, differential scanning calorimeter (DSC), scanning electron microscope (SEM). Study on temperature dependence of equilibrium swelling ratio showed that all IPN hydrogels exhibited temperature‐sensitivity. DSC further revealed that the temperature‐sensitivity was weakened with increasing amount of clay. Study on deswelling behavior revealed that IPN hydrogels had much faster response rate when comparing with PNIPAAm/clay hydrogels, and the response rate of IPN hydrogels could be controlled by clay content. SEM revealed that there existed difference in the interior morphology of IPN hydrogels between 20 [below lower critical solution temperature (LCST)] and 50 °C (above LCST), and this difference would become obvious with a decrease in clay content. For the standpoint of applications, oscillating swelling/deswelling behavior was investigated to determine whether properties of IPN hydrogels would be stable for potential applications. Bovine serum albumin (BSA) was used as model drug for in vitro experiment, the release data suggested that the controlled drug release could be achieved by modulating clay content. © 2008 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 47: 96–106, 2009